How Health-Related Social Media Can Complement Traditional Real-World Evidence Approaches to Offer Unique Patient Insights


Alison Booth, MSc
Research Associate
Real-World Evidence
Evidera, a PPD business

Traditional real-world evidence (RWE) is based on data collected in normal clinical practice outside of randomized controlled trials. It is used to complement clinical data in regulatory and health technology assessment submissions. This data is most often generated through retrospective or prospective observational studies using electronic health records, medical claims, disease registries, etc. As more emphasis is placed on the importance of RWE, other sources of useful real-world data have been identified, specifically social media. Online technology platforms have allowed patients to interact with each other and provide unique insight into specific diseases, conditions, and treatments. Mining this health-related social media data provides invaluable real-world data.

    What is Health-Related Social Media Data?

    When we think of social media, we typically think of generic sites like Facebook, Twitter, and Instagram. However, when discussing health-related social media we are referring to forums, blogs, and online communities that are often condition-specific and focus on discussions related to patient experiences such as the American Cancer Society’s Cancer Survivors Network, HealthUnlocked, and the Psoriasis Association. There are thousands of similar communities used by both patients and caregivers spanning a broad range of indications, making health-related social media a rich source of real-world evidence.

    Posts on these sites contain a vast amount of information ranging from a treatment or drug a patient has received and how long they have received it, information on symptoms and side effects, and subsequent impacts and questions to other community users. Figure 1 provides an annotated hypothetical post.

    Figure 1. Example of a Health-Related Social Media Post

      Social Media Listening as a Source of Real-World Data

      Health-related social media is constantly growing and gaining momentum as a complementary source of real-world data for both payers and regulators. For example, in June 2018, the United States Food and Drug Administration (FDA) encouraged the use of social media to shed light on the patient’s perspective, illustrating the increasing importance being placed on incorporation of the patient experience.1 In addition, the FDA has its own programs for and perspectives on collecting information about adverse events (AEs) from social media.2

      Another example illustrating the increasing importance placed on the patient experience is the proposed outcome-based payment model to link the price that the National Health Service (NHS) pays for a cancer drug to patient outcomes3 (See Figure 2). Certain outcomes evaluated are clinical in nature, and can typically be leveraged from traditional sources such as those mentioned earlier; however, many of the other outcomes such as emotions or social functioning can be challenging or even impossible to capture using traditional sources. These represent areas where health-related social media can be used to
      complement traditional studies to provide a comprehensive picture of patient outcomes and experiences.

        Figure 2. Value of a Drug for Patient vs. Only Efficacy/Safety3

          When Should Health-Related Social Media Be Considered?

          It is important to think about when it is appropriate and impactful to use health-related social media. These are typically situations when the patient or caregiver perspective and experience are of interest. Health-related social media can be appropriate to gain these insights as the content is driven by patients and caregivers themselves and is therefore more likely to represent topics important to patients that may not have been considered clinically or by the research team. Furthermore, health-related social media can be particularly insightful in the case of emerging conditions where little is known about the patient experience and perspective, such as COVID-19. In the case of rare diseases where large groups of patients can be hard to find, health-related social media forums may be a place where patients from many locations come together. The incorporation of health-related social media should be considered when conducting studies investigating the following:

            Unmet needs

            What elements patients and caregivers struggle with and research can help address

            Burden of disease

            Economic and time impacts, impacts on work, resource utilization, social impacts, and more

            Wider perspective of caregivers and family

            Caregivers often post on disease-specific social media forums, and patients also discuss the impacts of disease on their family

            Issues important to patients

            Content is driven by the topics patients spontaneously mention and wish to discuss

            Treatment experience

            Adverse events, holistic view of impacts on health-related quality of life, understanding of decision drivers for treatment choices, general opinions, perceptions and preferences about treatments

            Populations and indications hard to find in traditional databases

            Rare disease, rapidly progressing conditions, new/emerging diseases (e.g., COVID-19)

            Evidera has used health-related social media to inform patient preferences, study treatment patterns, perform sentiment analyses, gather patient and physician perceptions, enhance condition mapping to inform patient-reported outcome study design/instrument selection, analyze treatment decisions, and augment studies looking at safety by capturing adverse events.

              How Do We Use Health-Related Social Media Data?

              Once data is extracted from health-related social media sites, it needs to be analyzed in a way that produces useful insights that can be used to inform future clinical studies. There are several techniques that can be used to analyze the data (See Figure 3). Natural language processing (NLP) can be used to subset data to populations and discussions of interest, in addition to extracting frequently mentioned terms and topics. For example, Apache cTAKES is a natural language processing tool developed to extract clinical terms, such as disease symptoms or drugs, from text data. Custom lexicons can be derived using NLP to capture lay terms used by patients in addition to clinical terms. Machine learning (ML) has many applications but for social media data it can be particularly helpful to filter out noise (text that is not relevant to the study objective). Other applications of machine learning can also be explored based on specific study objectives. Qualitative data analysis is also important to social media data. The manual, in-depth analysis helps pull the full potential out of the data, allowing for deeper understanding of concepts and topics being discussed by patients.

              Figure 3. Common Types of Analyses

                General Aspects of Social Media Analyses

                We use posts from publicly available, condition-specific, social media forums to conduct studies. One consideration with health-related social media data is that the topics that may arise are not possible to specify a priori. Therefore, every social media study uses a scaled feasibility approach to mitigate risks and determine the appropriate sources and methods to use based on the specific research question.

                Health-related social media posts can contain a large quantity of noise that is challenging to remove. Evidera has developed supervised machine learning algorithms to predict whether posts contain a true patient experience, and those posts are carried forward for analysis. A mixed-methods approach, combining quantitative and qualitative analyses, is often used to extract the most value out of the data as possible.

                  Health-Related Social Media and Ethics

                  Ethical considerations are extremely important when using any data, especially patient privacy and appropriate use of the data. While there are no specific guidelines on the use of health-related social media data, we believe it is important to follow specific rules to protect the privacy of patients and caregivers. For example, it is important to read the terms and conditions for each site and check whether there are any restrictions around extracting the content. We also look at the robot files, which may indicate whether elements of text can be programmatically retrieved. Any forum where text elements cannot be retrieved would not
                  be extracted for a study. Additionally, only public, open-access forums should be used, as opposed to a closed forum that requires a login to view content, and researchers should not post to sites. This passive role is important for the integrity of the study and respect of patient privacy.

                  When using social media websites, seeking informed consent is often not feasible since it is not possible or practical to directly contact users. Per the ethics framework developed by the University of Sheffield,4 steps should be taken to protect patient privacy and retain anonymity. All data should be de-identified and anonymized and posts or post content should not be reproduced verbatim or in a manner that allows the original post to be identified from study outputs.

                    Example Social Media Studies

                    The following section provides examples of how to utilize health-related social media to address different research needs.

                    Emerging Diseases


                    Population: Patients with breast cancer

                    Challenge: COVID-19 emerged in late 2019 and was declared a global pandemic by the World Health Organization in March 2020. To date there have been over 40 million cases and over 1 million deaths related to COVID-19 globally (as of October 20, 2020).5 The aim was to understand the impact of COVID-19 on patients with other diseases, as well as their perceptions of COVID-19.

                    Approach: Extracted posts relating to COVID-19 from a large global breast cancer community and derived key themes and topics within the data using qualitative analyses.

                    Key Findings: The results of this study will be disseminated in late 2020, but we have already seen the prevalence of COVID-19 in health-related social media discussions. Realtime information and speed of access make social media a useful tool when information from other sources are lacking, such as with newly emerging diseases.

                      Rare Diseases

                      Using Social Media and Advanced Analytics to Inform
                      Study Design in AML and MDS6

                      Population: Patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy

                      Challenge: The population is difficult to capture due to the rapidly progressing nature of the disease. The challenge was to understand patient preferences regarding end-of-life treatment and to attempt to uncover unmet needs.

                      Approach: Posts from three AML/MDS-specific forums were extracted, and NLP was used to obtain posts from patients who were ineligible for intensive chemotherapy. We then conducted a targeted qualitative review to extract the patient and caregiver insights.

                      Findings: Findings from this study were presented at the American Society of Hematology 2018 annual conference and have been published in a manuscript.6 The study identified the desire of patients to be treated at home, suggested considerations for communicating information on treatment options, and highlighted the humanistic burden placed on patients and their caregivers.

                        Treatment Patterns

                        Extraction of Treatment Patterns from Health-Related Social Media Data

                        Population: Patients with metastatic renal cell carcinoma (RCC)

                        Challenge: To understand whether it is possible to accurately extract treatment patterns of patients with RCC in an automated manner from health-related social media data using natural language processing, rule-based decisions, and machine learning.

                        Approach: Posts from metastatic RCC patients were extracted through a machine learning algorithm. Receipt of treatments of interest was identified using NLP and line of therapy was defined as the order in which the therapies of interest were administered.

                        Findings: While this work was exploratory, it showed that the patterns derived from the social media sources were within the range of estimates from the published studies for the majority of the treatments investigated. Findings from this study have been published in a manuscript.7

                          Capturing Adverse Events

                          Adverse Event Profiling of Treatments for Breast Cancer

                          Population: Patients with breast cancer receiving chemotherapy, targeted therapy, or hormone therapy

                          Challenge: To identify symptoms and AEs from a large amount of unstructured text extracted from health-related social media forums to determine if this approach could provide novel information.

                          Approach: Posts were programmatically extracted from a large breast cancer community. After data cleaning and deidentification, AEs and symptom mentions were extracted using a lexical NLP approach, accounting for clinical and lay terms. Co-occurrences of treatment mentions, and symptom/AE mentions, were calculated for each treatment group (See Figures 4 and 5).

                          Findings: In addition to commonly reported symptoms and AEs, the study also uncovered less severe, or new and otherwise less frequently reported, symptoms/AEs that may have a significant impact on patients’ quality of life. Supplementing traditional approaches through analysis of social media can generate additional insights and can enhance current approaches toward incorporating the patient perspective into healthcare research. Findings from this study will be presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Europe conference in November 2020.

                          Figure 4. World Cloud AEs for Chemotherapy, Hormone Therapy and Targeted Therapy8

                            Figure 5. Heatmap of Top 25 Events Across Treatment Groups8


                              Health-related social media is a novel, growing, and constantly updated source of real-world data that has great value in uncovering patient experiences and perspectives. Outputs from health-related social media data can inform future research questions and its use can help provide a comprehensive understanding of treatment and disease outcomes, including outcomes not possible to capture in traditional sources of real-world data.


                                1. US Food and Drug Administration. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input: Guidance for Industry, Food and Drug Administration Staff, and other Stakeholders. June 2020. Available at: Accessed October 18, 2020.
                                2. US Food and Drug Administration. FDA Perspectives on Social Media for Postmarket Safety Monitoring. November 15, 2018. Available at: Accessed October 17, 2020.
                                3. Cole A, Cubi-Molla P, Pollard J, Sim D, Sullivan R, Sussex J, and Lorgelly P. (2019). Making Outcome-Based Payment a Reality in the NHS. Available at: Accessed October 17, 2020.
                                4. The University of Sheffield. Research Ethics Policy Note no. 14: Research Involving Social Media Data. Available at:!/file/Research-Ethics-Policy-Note-14.pdf. Published 2018. Accessed April 8, 2020.
                                5. World Health Organization. Coronavirus Disease (COVID-19) Pandemic. Available at: Accessed October 20, 2020.
                                6. Booth A, Bell T, Halhol S, et al. Using Social Media to Uncover Treatment Experiences and Decisions in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Who are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis. J Med Internet Res. 2019 Nov 22;21(11):e14285. doi: 10.2196/14285.
                                7. Ramagopalan SV, Malcolm B, Merinopoulou E, McDonald L, Cox A. Automated Extraction of Treatment Patterns from Social Media Posts: An Exploratory Analysis in Renal Cell Carcinoma. Future Oncol. 2019 Nov;15(31):3587-3596. doi: 10.2217/fon-2019-0406. Epub 2019 Sep 4.
                                8. Pan S, Halhol S, Booth A, Cox A, Merinopoulou E. Profiling of Disease Symptoms and Adverse Events: Does Social Media Augment Traditional Approaches? Presented at ISPOR 21st Annual European Congress – 2018; November 10-14, 2018; Barcelona, Spain.

                                  For more information, please contact
                                  [email protected]

                                  Download White Paper   Return to The Evidence Forum